Cresco Labs Inc.
CRLBF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $724,343 | $770,885 | $842,681 | $821,682 |
| % Growth | -6% | -8.5% | 2.6% | – |
| Cost of Goods Sold | $359,889 | $408,519 | $435,668 | $415,335 |
| Gross Profit | $364,454 | $329,886 | $407,013 | $406,347 |
| % Margin | 50.3% | 42.8% | 48.3% | 49.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $232,272 | $274,634 | $54,985 | $40,343 |
| SG&A Expenses | $232,272 | $274,634 | $350,653 | $317,804 |
| Sales & Mktg Exp. | $0 | $0 | $15,575 | $29,733 |
| Other Operating Expenses | $24,890 | $177,886 | $140,655 | $305,894 |
| Operating Expenses | $257,162 | $435,360 | $350,081 | $318,557 |
| Operating Income | $107,292 | -$87,823 | -$84,295 | -$217,351 |
| % Margin | 14.8% | -11.4% | -10% | -26.5% |
| Other Income/Exp. Net | -$117,908 | -$59,079 | -$42,610 | -$39,376 |
| Pre-Tax Income | -$10,616 | -$146,902 | -$126,905 | -$256,727 |
| Tax Expense | $49,873 | $32,950 | $88,938 | $40,107 |
| Net Income | -$74,438 | -$175,522 | -$212,047 | -$319,597 |
| % Margin | -10.3% | -22.8% | -25.2% | -38.9% |
| EPS | -0.22 | -0.54 | -0.71 | -1.22 |
| % Growth | 59.3% | 23.9% | 41.8% | – |
| EPS Diluted | -0.22 | -0.54 | -0.71 | -1.22 |
| Weighted Avg Shares Out | 345,474 | 323,820 | 298,162 | 262,326 |
| Weighted Avg Shares Out Dil | 345,474 | 323,820 | 298,162 | 262,326 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2,922 | $2,468 | $652 | $938 |
| Interest Expense | $58,901 | $64,403 | $58,516 | $52,149 |
| Depreciation & Amortization | $62,824 | $69,304 | $55,438 | $44,553 |
| EBITDA | $108,791 | -$14,618 | -$10,241 | -$157,039 |
| % Margin | 15% | -1.9% | -1.2% | -19.1% |